A yeast artificial chromosome contig containing the complete Duchenne muscular dystrophy gene.

[1]  D. Bentley,et al.  Construction of a 2.6-Mb contig in yeast artificial chromosomes spanning the human dystrophin gene using an STS-based approach. , 1992, Genomics.

[2]  H Sugita,et al.  Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. , 1991, American journal of human genetics.

[3]  A. Monaco,et al.  Mapping irradiation hybrids to cosmid and yeast artificial chromosome libraries by direct hybridization of Alu-PCR products. , 1991, Nucleic acids research.

[4]  A. Monaco,et al.  Yeast artificial chromosome libraries containing large inserts from mouse and human DNA. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Nobelstiftelsen,et al.  Etiology of Human Disease at the DNA Level , 1991 .

[6]  L. Kunkel,et al.  Dystrophin is transcribed in brain from a distant upstream promoter. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Chapelle,et al.  Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies , 1990, Cell.

[8]  M. Olson,et al.  Chromosomal region of the cystic fibrosis gene in yeast artificial chromosomes: a model for human genome mapping. , 1990, Science.

[9]  H. Lehrach,et al.  Yeast artificial chromosomes: an alternative approach to the molecular analysis of mouse developmental mutations. , 1990, Genetical research.

[10]  M. W. Thompson,et al.  Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotypegenotype correlation. , 1990, American journal of human genetics.

[11]  C. van Broeckhoven,et al.  Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. , 1989, American journal of human genetics.

[12]  L. Kunkel,et al.  The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. , 1989, American journal of human genetics.

[13]  L. Hood,et al.  A common language for physical mapping of the human genome. , 1989, Science.

[14]  J. D. den Dunnen,et al.  High resolution deletion breakpoint mapping in the DMD gene by whole cosmid hybridization. , 1989, Nucleic acids research.

[15]  L. Kunkel,et al.  Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus , 1989, Nature.

[16]  C. Caskey,et al.  Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies , 1989, Neurology.

[17]  L. Kunkel,et al.  Complementary DNA probes for the Duchenne muscular dystrophy locus demonstrate a previously undetectable deletion in a patient with dystrophic myopathy, glycerol kinase deficiency, and congenital adrenal hypoplasia. , 1989, The Journal of clinical investigation.

[18]  M. W. Thompson,et al.  Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. , 1988, Science.

[19]  A. Coulson,et al.  Genome linking with yeast artificial chromosomes , 1988, Nature.

[20]  A. Monaco,et al.  The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein , 1988, Cell.

[21]  A. Monaco,et al.  A 10-megabase physical map of human Xp21, including the Duchenne muscular dystrophy gene. , 1988, Genomics.

[22]  U. Francke,et al.  Intragenic deletions in 21 Duchenne muscular dystrophy (DMD)/Becker muscular dystrophy (BMD) families studied with the dystrophin cDNA: location of breakpoints on HindIII and BglII exon-containing fragment maps, meiotic and mitotic origin of the mutations. , 1988, American journal of human genetics.

[23]  A. Monaco,et al.  An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. , 1988, Genomics.

[24]  C. Bertelson,et al.  Long-range genomic map of the Duchenne muscular dystrophy (DMD) gene: isolation and use of J66 (DXS268), a distal intragenic marker. , 1987, Genomics.

[25]  R. Heilig,et al.  A 230kb cosmid walk in the Duchenne muscular dystrophy gene: detection of a conserved sequence and of a possible deletion prone region. , 1987, Nucleic acids research.

[26]  J. D. Dunnen,et al.  Direct detection of more than 50% of the Duchenne muscular dystrophy mutations by field inversion gels , 1987, Nature.

[27]  K. Davies,et al.  Preferential deletion of exons in Duchenne and Becker muscular dystrophies , 1987, Nature.

[28]  M. Koenig,et al.  Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals , 1987, Cell.

[29]  M. Olson,et al.  Cloning of large segments of exogenous DNA into yeast by means of artificial chromosome vectors. , 1987, Science.

[30]  K. Fischbeck,et al.  Molecular analysis of the Duchenne muscular dystrophy region using pulsed field gel electrophoresis , 1987, Cell.

[31]  P. Ray,et al.  A cDNA clone from the Duchenne/Becker muscular dystrophy gene , 1987, Nature.

[32]  Hans Lehrach,et al.  Long-range restriction map around the Duchenne muscular dystrophy gene , 1986, Nature.

[33]  A. Monaco,et al.  A physical map of 4 million bp around the Duchenne muscular dystrophy gene on the human X-chromosome , 1986, Cell.

[34]  A. Monaco,et al.  Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene , 1986, Nature.

[35]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.